A detailed history of Curat Global, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Curat Global, LLC holds 3,135 shares of ABT stock, worth $407,644. This represents 0.39% of its overall portfolio holdings.

Number of Shares
3,135
Previous 3,135 -0.0%
Holding current value
$407,644
Previous $426 Million 1.52%
% of portfolio
0.39%
Previous 0.41%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 01, 2025

SELL
$123.95 - $138.08 $247,900 - $276,160
-2,000 Reduced 38.95%
3,135 $426 Million
Q1 2025

Apr 11, 2025

BUY
$111.1 - $140.22 $570,498 - $720,029
5,135 New
5,135 $681 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Curat Global, LLC Portfolio

Follow Curat Global, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Curat Global, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Curat Global, LLC with notifications on news.